Konstantinos Imprialos Selected Research

Konstantinos Imprialos Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
6	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2018
6	Hypertension (High Blood Pressure) 01/2020 - 04/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
5	Heart Failure 08/2022 - 01/2017
3	Body Weight (Weight, Body) 12/2019 - 01/2017
2	Diabetes Mellitus 01/2022 - 01/2017
2	COVID-19 01/2022 - 10/2020
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Alcoholic Fatty Liver 01/2021 - 01/2018
2	Albuminuria 01/2021 - 01/2017
2	Infections 10/2020 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 01/2018
2	Stroke (Strokes) 01/2019 - 07/2016
2	Neoplasms (Cancer) 01/2018 - 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023
1	Chronic Renal Insufficiency 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Critical Illness (Critically Ill) 10/2020
1	Disease Progression 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 07/2020
1	Erectile Dysfunction 01/2020
1	Insulin Resistance 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 12/2019
1	Hemorrhagic Stroke 01/2018
1	Arteritis 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2018
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2018
1	Atherosclerosis 01/2018
1	Obstructive Sleep Apnea 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2016
1	Atrial Fibrillation 07/2016

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2019
8	SodiumIBA 08/2022 - 01/2019
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2018
4	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2017
3	Atorvastatin (Lipitor)FDA Link 01/2021 - 01/2018
3	Insulin (Novolin)FDA Link 07/2020 - 01/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2019 - 01/2019
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2017
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2017
2	SymportersIBA 08/2022 - 10/2019
2	Mineralocorticoid Receptor AntagonistsIBA 08/2022 - 01/2017
2	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2022 - 01/2017
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 10/2019 - 01/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2019
2	Pioglitazone (Actos)FDA Link 01/2019 - 01/2018
2	oxidized low density lipoproteinIBA 01/2018 - 01/2018
1	HDL CholesterolIBA 04/2023
1	C-Reactive ProteinIBA 01/2021
1	pitavastatin (itavastatin)FDA Link 01/2021
1	nasIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	IronIBA 01/2020
1	Ezetimibe (Zetia)FDA Link 01/2019
1	PTX3 proteinIBA 01/2019
1	LeptinIBA 01/2019
1	ThiazolidinedionesIBA 01/2019
1	MineralocorticoidsIBA 12/2018
1	LDL CholesterolIBA 01/2018
1	canakinumab FDA Link 01/2018
1	EnzymesIBA 01/2018
1	LipidsIBA 01/2018
1	Trinitrotoluene (TNT)IBA 01/2018
1	Vitamin E FDA LinkGeneric 01/2018
1	FibrinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	finerenoneIBA 01/2017
1	RivaroxabanIBA 07/2016
1	Warfarin (Coumadin)FDA LinkGeneric 07/2016
1	Spironolactone (Aldactone)FDA LinkGeneric 04/2016

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2016
2	Glycemic Control 12/2019 - 01/2018
1	Secondary Prevention 01/2021
1	Denervation 01/2020
1	Catheters 01/2020
1	Drug Therapy (Chemotherapy) 01/2017
1	Renal Dialysis (Hemodialysis) 11/2016
1	Polypharmacy 07/2016